Share

July 8, 2008; 71 (2)

Share

A

  1. Adami, A.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  2. Ade-Hall, R. A.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  3. Alonso, Alvaro

    1. Temporal trends in the incidence of multiple sclerosisA systematic review
      Alvaro Alonso, Miguel A. Hernán

  4. Ames, M. H.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  5. Anzola, G. P.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  6. Arzy, Shahar

    1. PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSIS
      Shahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker

B

  1. Ben-Hur, Tamir

    1. PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSIS
      Shahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker

  2. Bhatt, Archit

    1. Teaching NeuroImage: Spindle cell oncocytoma of the pituitary gland
      Muhammad U. Farooq, Archit Bhatt, Howard T. Chang

  3. Blatt, J. L.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  4. Bleuse, S.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  5. Byrd, S. C.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

C

  1. Castellotti, B.

    1. Paroxysmal movement disorders in GLUT1 deficiency syndrome
      G. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci

  2. Cerini, R.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  3. Chang, Howard T.

    1. Teaching NeuroImage: Spindle cell oncocytoma of the pituitary gland
      Muhammad U. Farooq, Archit Bhatt, Howard T. Chang

  4. Clement, F.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  5. Cole, G. M.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  6. Couch, J. R.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  7. Cummings, J. L.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

D

  1. Defebvre, L.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  2. Destée, A.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  3. Devos, D.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  4. Dwyer, M. G.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

F

  1. Farooq, Muhammad U.

    1. Teaching NeuroImage: Spindle cell oncocytoma of the pituitary gland
      Muhammad U. Farooq, Archit Bhatt, Howard T. Chang

  2. Fein, J.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  3. Filippi, M.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  4. Finocchi, C.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  5. Fontoura, P.

    1. Hourglass brain
      R. M. Guerreiro, P. Fontoura

  6. Frohman, E. M.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  7. Fryer, J. P.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

G

  1. Gellera, C.

    1. Paroxysmal movement disorders in GLUT1 deficiency syndrome
      G. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci

  2. Geschwind, D. H.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  3. Goldstein, J.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  4. Guerreiro, R. M.

    1. Hourglass brain
      R. M. Guerreiro, P. Fontoura

  5. Gylys, K. H.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

H

  1. Hernán, Miguel A.

    1. Temporal trends in the incidence of multiple sclerosisA systematic review
      Alvaro Alonso, Miguel A. Hernán

  2. Homburger, H.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  3. Howieson, D. B.

    1. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
      L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye

  4. Hunter, J.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

K

  1. Kaye, J. A.

    1. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
      L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye

  2. Khan, O.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  3. Krecke, K.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  4. Krystkowiak, P.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  5. Kuntz, N. L.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

L

  1. Lanska, Douglas J.

    1. RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS
      Douglas J. Lanska

  2. Lassmann, H.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  3. Leker, Ronen R.

    1. PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSIS
      Shahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker

  4. Lener, S. E.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  5. Lennon, V. A.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  6. Ljøstad, Unn

    1. RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS
      Unn Ljøstad, Åse Mygland

  7. Lotze, T.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  8. Lucchinetti, C. F.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

M

  1. Mannix, L. K.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  2. McDonald, S. A.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  3. McKeon, A.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  4. Medina, L. D.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  5. Mehta, Brijesh P.

    1. Teaching NeuroImage: Cerebrotendinous xanthomatosis
      Brijesh P. Mehta, Robert H. Shmerling

  6. Meneghetti, G.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  7. Minagar, A.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  8. Mohamed, K.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  9. Moore, A. P.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  10. Moore, M. M.

    1. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
      L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye

  11. Moreau, C.

    1. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
      C. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
      CME Course

  12. Mygland, Åse

    1. RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS
      Unn Ljøstad, Åse Mygland

N

  1. Nardocci, N.

    1. Paroxysmal movement disorders in GLUT1 deficiency syndrome
      G. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci

  2. Nelson, C.

    1. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
      L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye

  3. Ness, J. M.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  4. Newman, J. P.

    1. PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSIS
      Shahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker

P

  1. Pittock, S. J.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  2. Pozzi-Mucelli, R.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  3. Pratico, D.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

Q

  1. Quinn, Joseph

    1. Detecting Alzheimer disease before it happensThe key to prevention?
      Joseph Quinn, Marwan N. Sabbagh

R

  1. Racke, M. K.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  2. Reder, A. T.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  3. Rensel, M.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  4. Ringman, J. M.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  5. Rodriguez-Agudelo, Y.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  6. Rosario, E. R.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  7. Rosenbloom, L.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  8. Rossato, G.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

S

  1. Sabbagh, Marwan N.

    1. Detecting Alzheimer disease before it happensThe key to prevention?
      Joseph Quinn, Marwan N. Sabbagh

  2. Schaffer, B.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  3. Seltzer, W.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  4. Sette, M. Del

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  5. Shmerling, Robert H.

    1. Teaching NeuroImage: Cerebrotendinous xanthomatosis
      Brijesh P. Mehta, Robert H. Shmerling

  6. Silberstein, S. D.

    1. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine
      S. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener

  7. Silbert, L. C.

    1. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
      L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye

  8. Smith, C. Tudu

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  9. Sokolow, S.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

  10. Stüve, O.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

T

  1. Tagliati, Michele

    1. Fine-tuning gait in Parkinson disease
      Michele Tagliati

  2. Tenenbaum, S.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  3. Thijs, V. N.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

V

  1. Varpetian, A.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

W

  1. Walsh, H.P.J.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

  2. Weinshenker, B. G.

    1. CNS aquaporin-4 autoimmunity in children
      A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock

  3. Williamson, P. R.

    1. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy
      A. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson

Y

  1. Younkin, S. G.

    1. Biochemical markers in persons with preclinical familial Alzheimer disease
      J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
      CME Course

Z

  1. Zanferrari, C.

    1. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients
      A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari

  2. Zibordi, F.

    1. Paroxysmal movement disorders in GLUT1 deficiency syndrome
      G. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci

  3. Zivadinov, R.

    1. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
      R. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan

  4. Zorzi, G.

    1. Paroxysmal movement disorders in GLUT1 deficiency syndrome
      G. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Back to top
Subscribe to e-Alerts
RSS
Advertisement
Advertisement